HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer.

Abstract
Pharmacologic ascorbate (P-AscH-) is emerging as a promising adjuvant for advanced pancreatic cancer. P-AscH- generates hydrogen peroxide (H2O2), leading to selective cancer cell cytotoxicity. Catalytic manganoporphyrins, such as MnT4MPyP, can increase the rate of oxidation of P-AscH-, thereby increasing the flux of H2O2, resulting in increased cytotoxicity. We hypothesized that a multimodal treatment approach, utilizing a combination of P-AscH-, ionizing radiation and MnT4MPyP, would result in significant flux of H2O2 and pancreatic cancer cytotoxicity. P-AscH- with MnT4MPyP increased the rate of oxidation of P-AscH- and produced radiosensitization in all pancreatic cancer cell lines tested. Three-dimensional (3D) cell cultures demonstrated resistance to P-AscH-, radiation or MnT4MPyP treatments alone; however, combined treatment with P-AscH- and MnT4MPyP resulted in the inhibition of tumor growth, particularly when also combined with radiation. In vivo experiments using a murine model demonstrated an increased rate of ascorbate oxidation when combinations of P-AscH- with MnT4MPyP were given, thus acting as a radiosensitizer. The translational potential was demonstrated by measuring increased ascorbate oxidation ex vivo, whereby MnT4MPyP was added exogenously to plasma samples from patients treated with P-AscH- and radiation. Combination treatment utilizing P-AscH-, manganoporphyrin and radiation results in significant cytotoxicity secondary to enhanced ascorbate oxidation and an increased flux of H2O2. This multimodal approach has the potential to be an effective treatment for pancreatic ductal adenocarcinoma.
AuthorsMatthew S Alexander, Brianne R O'Leary, Justin G Wilkes, Adrienne R Gibson, Brett A Wagner, Juan Du, Ehab Sarsour, Rosa F Hwang, Garry R Buettner, Joseph J Cullen
JournalRadiation research (Radiat Res) Vol. 191 Issue 1 Pg. 43-51 (01 2019) ISSN: 1938-5404 [Electronic] United States
PMID30376411 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Metalloporphyrins
  • Radiation-Sensitizing Agents
  • tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex
  • Ascorbic Acid
Topics
  • Animals
  • Ascorbic Acid (metabolism)
  • Cell Line, Tumor
  • Disease Models, Animal
  • Drug Synergism
  • Electron Spin Resonance Spectroscopy
  • Humans
  • Metalloporphyrins (therapeutic use)
  • Oxidation-Reduction
  • Pancreatic Neoplasms (drug therapy, metabolism, pathology, radiotherapy)
  • Radiation-Sensitizing Agents (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: